"Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcin

• 作 者: JianyongLei;LunanYan;WentaoWang;
• 机 构: 四川大学华西医院
• 出 处: 2014中国器官移植大会
• 发表日期: 2014年期

　　Background and Aims:The"Metroticket"prognostic model for survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) treatment has been implemented for several years.The aim of our study was to validate the"Metroticket"predictor using a large cohort ofLT patients with HCC in China.